The macrophage heterogeneity: Difference between mouse peritoneal exudate and splenic F4/80+ macrophages

Journal of Cellular Physiology

Volumn 209, Issue 2, 2006, Pages 341-352

  Liu, Guangwei ^a   Xia, Xue Pei ^b   Gong, Shou Liang ^c   Zhao, Yong ^a  

^a INSTITUTE OF ZOOLOGY   (China)

^b Beijing Haidian Hospital   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD23 ANTIGEN; CD40 ANTIGEN; CELL SURFACE MARKER; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ALLOTYPE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL COUNT; CELL CULTURE; CELL HETEROGENEITY; CELL ISOLATION; CELL METABOLISM; CELL SHAPE; CELL STIMULATION; CELL SURFACE; CHICKEN; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; ERYTHROCYTE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; IMMUNOGENICITY; IMMUNOSTIMULATION; INNATE IMMUNITY; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEAL EXUDATE CELL; PERITONEAL EXUDATE MACROPHAGE; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; SPLEEN MACROPHAGE; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD80; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHICKENS; EXUDATES AND TRANSUDATES; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NITRIC OXIDE; PHAGOCYTOSIS; PHENOTYPE; SPLEEN; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 33749245144     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20732     Document Type: Article

References (38)

1. Ammon C, Meyer SP, Schwarzfischer L, Krause SW, Andreesen R, Kreutz M. 2000. Comparative analysis of integrin expression on monocyte-derived macrophages and monocyte-derived dendritic cells. Immunology 100:364-369.
2. Anderson CF, Mosser DM. 2002. A novel phenotype for an activated macrophage: The type 2 activated macrophage. J Leukoc Biol 72:101-106.
3. Barrington R, ZhangM, Fischer M, Carroll MC. 2001. The role of complement in inflammation and adaptive immunity. Immunol Rev 180:5-15.
4. Belardelli F, Ferrantini M. 2002. Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol 23:201-208.
5. Cailhier JF, Partolina M, Vuthoori S, Wu S, Ko K, Watson S, Savill J, Hughes J, Lang RA. 2005. Conditional macrophage ablation demonstrates that resident macrophages initiate acute peritoneal inflammation. J Immunol 174:2336-2342.
6. Chakraborty D, Banerjee S, Sen A, Banerjee KK, Das P, Roy S. 2005. Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts. J Immunol 175:3214-3224.
7. Chomarat P, Dantin C, Bennett L, Banchereau J, Palucka AK. 2003. TNF skews monocyte differentiation from macrophages to dendritic cells. J Immunol 171:2262-2269.
8. Delneste Y, Charbonnier P, Herbault N, Magistrelli G, Caron G, Bonnefoy JY, Jeannin P. 2003. Interferon-gamma switches monocyte differentiation from dendritic cells to macrophages. Blood 101:143-150.
9. + thymic macrophages as professional scavengers of apoptotic thymocytes. J Immunol 171:2773-2777.
10. Gordon S. 2003. Alternative activation of macrophages. Nat Rev Immunol 3:23-35.
11. Gordon S. 2004. Pathogen recognition or homeostasis? APC receptor functions in innate immunity. C R Biol 327:603-607.
12. Kaufmann SH, Schaible UE. 2005. Antigen presentation and recognition in bacterial infections. Curr Opin Immunol 17:79-87.
13. Lee JK, Byun JA, Park SH, Choi HJ, Kim HS, Oh HY. 2005a. Evaluation of the potential immunotoxicity of 3-monochloro-1,2-propanediol in Balb/c mice II. Effect on thymic subset, delayed-type hypersensitivity, mixed-lymphocyte reaction, and peritoneal macrophage activity. Toxicology 211:187-196.
14. Lee JK, Ryu MH, Byun JA. 2005b. Immunotoxic effect of beta-chlorolactic acid on murine splenocyte and peritoneal macrophage function in vitro. Toxicology 210:175-187.
15. Lin HH, Faunce DE, Stacey M, Terajewicz A, Nakamura T, Zhang-Hoover J, Kerley M, Mucenski ML, Gordon S, Stein-Streilein J. 2005. The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance. J Exp Med 201:1615-1625.
16. Liu G, Gong XL, Zhao Y. 2005a. Alternative activated macrophage and its immunoregulatory effects. Bull Med Res 34:65-68.
17. Liu G, Xia XP, Zhao Y. 2005b. Research progress in Toll-like receptor signal pathways. Chin J Zool 40:117-121.
18. Liu G, Wu Y, Gong S, Zhao Y. 2006. Toll-like receptors and graft rejection. Transpl Immunol 16:25-31.
19. Millard AL, Mertes PM, Ittelet D, Villard F, Jeannesson P, Bernard J. 2002. Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages. Clin Exp Immunol 130:245-255.
20. Minto AW, Erwig LP, Rees AJ. 2003. Heterogeneity of macrophage activation in anti-Thy-1.1 nephritis. Am J Pathol 163:2033-2041.
21. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, Manning S, Greenfield EA, Coyle AJ, Sobel RA, Freeman GJ, Kuchroo VK. 2002. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415:536-541.
22. Morrison AC, Wilson CB, Ray M, Correll PH. 2004 Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide. J Immunol 172:1825-1832.
23. Ogle CK, Wu JZ, Mao X, Szczur K, Alexander JW, Ogle JD. 1994. Heterogeneity of Kupffer cells and splenic, alveolar, and peritoneal macrophages for the production of TNF, IL-1, and IL-6. Inflammation 18:511-523.
24. Olsson S, Sundler R. 2006. The role of lipid rafts in LPS-induced signaling in a macrophage cell line. Mol Immunol 43:607-612.
25. Ravasi T, Wells C, Forest A, Underhill DM, Wainwright BJ, Aderem A, Grimmond S, Hume DA. 2002. Generation of diversity in the innate immune system: Macrophage heterogeneity arises from gene-autonomous transcriptional probability of individual inducible genes. J Immunol 168:44-50.
26. Raychaudhuri B, Fisher CJ, Farver CF, Malur A, Drazba J, Kavuru MS, Thomassen MJ. 2000. Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages. Cytokine 12:1348-1355.
27. Shortman K, Wu L. 2004. Are dendritic cells end cells? Nat Immunol 5:1105-1106.
28. Sodhi A, Sharma RK, Batra HV. 2005. Yersinia rLcrV and rYopB inhibits the activation of murine peritoneal macrophages in vitro. Immunol Lett 99:146-152.
29. Stout RD, Suttles J. 2005. Immunosenescence and macrophage functional plasticity: Dysregulation of macrophage function by age-associated microenvironmental changes. Immunol Rev 205:60-71.
30. Stout RD, Jiang C, Matta B, Tietzel I, Watkins SK, Suttles J. 2005. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 175:342-349.
31. Sun Y, Ge BS, Kasai M, Diffendaffer C, Parks N, Li H, Peng J, Langnas AN, Zhao Y. 2006. Induction of regulatory T cells from mature T cells by allogeneic thymic epithelial cells in vitro. Transpl Int 19:404-414.
32. Swirski FK, Gajewska BU, Robbins CS, D'Sa A, Johnson JR, Pouladi MA, Inman MD, Stampfli MR. 2004. Concomitant airway expression of granulocyte-macrophage colony-stimulating factor and decorin, a natural inhibitor of transforming growth factor-beta, breaks established inhalation tolerance. Eur J Immunol 34:2375-2386.
33. Troelstra A, de Graaf-Miltenburg LA, van Bommel T, Verhoef J, Van Kessel KP, Van Strijp JA. 1999. Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18. J Immunol 162:4220-4225.
34. Wu JZ, Ogle CK, Ogle JD, Alexander JW. 1993. A comparison of hepatic, splenic, peritoneal and alveolar macrophages with respect to PGE2, TXB2, production and ADCC function. Prostaglandins Leukot Essent Fatty Acids 48:149-153.
35. Wysocka M, Robertson S, Riemann H, Caamano J, Hunter C, Mackiewicz A, Montaner LJ, Trinchieri G, Karp CL. 2001. IL-12 suppression during experimental endotoxin tolerance: Dendritic cell loss and macrophage hyporesponsiveness. J Immunol 166:7504-7513.
36. Yan SR, Al-Hertani W, Byers D, Bortolussi R. 2002. Lipopolysaccharide- binding protein- and CD14-dependent activation of mitogen-activated protein kinase p38 by lipopolysaccharide in human neutrophils is associated with priming of respiratory burst. Infect Immun 70:4068-4074.
37. Zhao Y, Ohdan H, Manilay JO, Sykes M. 2003a. NK cell tolerance in mixed allogeneic chimeras. J Immunol 170:5398-5405.
38. Zhao Y, Xiong W, Yang T, Prall A, Baxter BT, Langnas AN. 2003b. Xenogeneic skin graft rejection in M-CSF/macrophage deficient osteopetrotic mice. Xenotransplantation 10:232-239.